You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-EGF-Like-Domain, Multiple 7 (EGFL7) Antibodies

EGFL7 encodes a secreted endothelial cell protein that contains two epidermal growth factor-like domains. Additionally we are shipping EGFL7 Kits (14) and EGFL7 Proteins (10) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
EGFL7 353156 Q9QXT5
EGFL7 51162 Q9UHF1
EGFL7 245963 Q6AZ60
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-EGFL7 Antibodies at antibodies-online.com

Showing 10 out of 56 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated IF (cc), IF (p), IHC (p), WB Formalin-fixed and paraffin embedded human colon carcinoma labeled with Anti-EGFL7 Polyclonal Antibody, Unconjugated (ABIN733988) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL Log in to see 3 to 7 Days
$269.50
Details
Human Rabbit Un-conjugated IHC (p) 7 mL Log in to see 21 to 31 Days
$237.00
Details
Human Mouse Un-conjugated ELISA Detection limit for recombinant GST tagged EGFL7 is approximately 3ng/ml as a capture antibody. 100 μg Log in to see 9 Days
$430.00
Details
Human Mouse Un-conjugated ELISA, WB Detection limit for recombinant GST tagged EGFL7 is approximately 0.03ng/ml as a capture antibody. Western Blot detection against Immunogen (53.24 KDa) . 100 μg Log in to see 9 Days
$430.00
Details
Human Mouse Un-conjugated ELISA, WB Detection limit for recombinant GST tagged EGFL7 is approximately 0.03 ng/mL as a capture antibody. 0.1 mg Log in to see 8 to 11 Days
$450.00
Details
Human Mouse Un-conjugated ELISA Detection limit for recombinant GST tagged EGFL7 is approximately 3 ng/mL as a capture antibody. 0.1 mg Log in to see 8 to 11 Days
$450.00
Details
Human Rabbit Un-conjugated IHC (fro), IF, WB   0.1 mg Log in to see 6 to 8 Days
$308.00
Details
Human Rabbit Alexa Fluor 594 IF (cc), IF (p)   100 μL Log in to see 14 to 21 Days
$357.50
Details
Human Rabbit Alexa Fluor 555 IF (cc), IF (p)   100 μL Log in to see 14 to 21 Days
$357.50
Details
Human Rabbit Alexa Fluor 350 IF (cc), IF (p)   100 μL Log in to see 14 to 21 Days
$357.50
Details

EGFL7 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Mouse (Murine) , ,
,
,
, , , , , , , , , , ,
Human , , , ,
, ,
,
, , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , ,

Top referenced anti-EGFL7 Antibodies

  1. Human Polyclonal EGFL7 Primary Antibody for IF (cc), IF (p) - ABIN733988 : Huang, Yuan, Wan, Liu, Chen, Zhan, Li: VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network. in International journal of clinical and experimental pathology 2014 (PubMed)

  2. Human Monoclonal EGFL7 Primary Antibody for ELISA, WB - ABIN565550 : Fish, Santoro, Morton, Yu, Yeh, Wythe, Ivey, Bruneau, Stainier, Srivastava: miR-126 regulates angiogenic signaling and vascular integrity. in Developmental cell 2008 (PubMed)

  3. Human Monoclonal EGFL7 Primary Antibody for ELISA - ABIN565551 : Badiwala, Tumiati, Joseph, Sheshgiri, Ross, Delgado, Rao: Epidermal growth factor-like domain 7 suppresses intercellular adhesion molecule 1 expression in response to hypoxia/reoxygenation injury in human coronary artery endothelial cells. in Circulation 2010 (PubMed)

More Antibodies against EGFL7 Interaction Partners

Xenopus laevis EGF-Like-Domain, Multiple 7 (EGFL7) interaction partners

  1. we demonstrate for the first time the mechanisms by which lumens are generated within the major vessels in Xenopus and implicate EGFL7 in modulating cell shape and cell-cell junctions to drive proper lumen morphogenesis.

  2. CASZ1 (show CASZ1 Antibodies)/Egfl7/RhoA (show RHOA Antibodies) pathway is necessary for promoting endothelial cell behaviors associated with proper vascular assembly.

Zebrafish EGF-Like-Domain, Multiple 7 (EGFL7) interaction partners

  1. These data suggest that Egfl7 provides endothelial cells (EC) with a cue for their extension into the vascular area and in establishing EC cell polarity.

  2. EGFL7 provides a proper microenvironment for endothelial cell migration, thereby enabling accurate patterning.

Mouse (Murine) EGF-Like-Domain, Multiple 7 (EGFL7) interaction partners

  1. EGFL7 is required for VEGF (show VEGFA Antibodies) upregulation of the Akt (show AKT1 Antibodies)/Erk (1 (show MAPK3 Antibodies)/2) pathway during angiogenesis.

  2. EGFL7 enhances EGFR (show EGFR Antibodies)-AKT (show AKT1 Antibodies) signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.

  3. Egfl7 could be a HIF-1alpha (show HIF1A Antibodies) responsive gene regulated by oxygen tension.

  4. Using the BPH/5 model of pre-eclampsia (PE), we show that the downregulation of Egfl7 in compromised placentas occurs pr (show NOTCH1 Antibodies)ior to the onset of characteristic maternal signs of PE.

  5. egfl7 is initially expressed in all endothelial cells and then is progressively restricted to veins and to their neighbouring capillaries.

  6. EGFL7 is expressed in the bone microenvironment and has a role in promoting endothelial cell migration and tube-like structure formation through integrin-mediated pathways.

  7. Expression of Egfl7 in breast and lung carcinoma cells accelerates tumor growth and metastasis in immunocompetent mice but not in immunodeficient mice.

  8. Overexpression of endothelial Egfl7 is associated with impaired angiogenesis and altered Notch (show NOTCH1 Antibodies) signaling

  9. the expression of the VE-statin/egfl7 gene in endothelial cells and the specific importance of ETS (show ETS1 Antibodies) and GATA (show QRSL1 Antibodies) factors

  10. EGFL7 protein is localized to the endoplasmic reticulum and Golgi apparatus, suggesting that the protein is targeted for secretion

Human EGF-Like-Domain, Multiple 7 (EGFL7) interaction partners

  1. The preferential expression of EGFL7 in less differentiated hepatocellular carcinoma compared to VEGF (show VEGFA Antibodies), suggests a possible important role of this angiogenic factor (show VEGFA Antibodies) in a later oncogenic and infiltrative/metastatic phase.

  2. EGFR (show EGFR Antibodies) mutational analysis is useful in the diagnosis of non-small-cell-lung cancer.

  3. The aim of the present descriptive study was to analyse the intra-tumoural expressions of epidermal growth factor (show EGF Antibodies)-like domain 7 (EGFL7) and microRNA-126 (miRNA-126) in primary tumours from patients with stage II-IV colorectal cancer.

  4. EGFL7, OPN (show SPP1 Antibodies), and PGE2 may have a role in recurrence and metastasis of hepatocellular carcinoma

  5. High EGFL7 expression promotes migration and Epithelial-Mesenchymal Transition in pancreatic Cancer.

  6. Loss of EGFL7 expression is associated with Malignant Pleural Mesothelioma.

  7. Data suggest that, in trophoblast cells, EGFL7 regulates cell migration and invasion/placentation by activating multiple signaling pathways via MAPK (show MAPK1 Antibodies), PI3K (show PIK3CA Antibodies) (phosphatidylinositol 3-kinase), and NOTCH1 (show NOTCH1 Antibodies) (translocation-associated notch (show NOTCH1 Antibodies) protein 1).

  8. EGFL7 may predict response to first-line chemotherapy and bevacizumab in patients with metastatic colorectal cancer

  9. Endothelial cells control pancreatic cell fate at defined stages through EGFL7 signaling.

  10. EGFL7 enhances EGFR (show EGFR Antibodies)-AKT (show AKT1 Antibodies) signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.

EGFL7 Antigen Profile

Protein Summary

This gene encodes a secreted endothelial cell protein that contains two epidermal growth factor-like domains. The encoded protein may play a role in regulating vasculogenesis. This protein may be involved in the growth and proliferation of tumor cells. Alternate splicing results in multiple transcript variants.

Gene names and symbols associated with EGFL7

  • EGF-like-domain, multiple 7 (egfl7) antibody
  • EGF-like-domain, multiple 7 (EGFL7) antibody
  • EGF-like-domain, multiple 7 (LOC100226311) antibody
  • EGF-like domain 7 (Egfl7) antibody
  • EGF-like-domain, multiple 7 (Egfl7) antibody
  • EGFL7 antibody
  • MGC53105 antibody
  • MGC147423 antibody
  • NEU1 antibody
  • RP11-251M1.2 antibody
  • VE-STATIN antibody
  • xegfl7 antibody
  • zgc:136669 antibody
  • zgc:152804 antibody
  • ZNEU1 antibody

Protein level used designations for EGFL7

EGF-like-domain, multiple 7 , epidermal growth factor-like protein 7 , rp11-251m1.2 , EGF-like protein 7 , NEU1 protein , NOTCH4-like protein , multiple EGF-like domains protein 7 , multiple epidermal growth factor-like domains protein 7 , vascular endothelial statin , vascular endothelial-statin , EGF-like domain 7 , EGF-like domain-containing protein 7 , Estrogen-regulated protein CBL20 20.4kD , Estrogen-regulated protein CBL20, 20.4kD , multiple EGF-like domain protein 7 , multiple epidermal growth factor-like domain protein 7

GENE ID SPECIES
379835 Xenopus laevis
417137 Gallus gallus
464868 Pan troglodytes
491250 Canis lupus familiaris
613671 Bos taurus
678640 Danio rerio
780371 Xenopus (Silurana) tropicalis
100226311 Taeniopygia guttata
353156 Mus musculus
51162 Homo sapiens
245963 Rattus norvegicus
Selected quality suppliers for anti-EGFL7 (EGFL7) Antibodies
Did you look for something else?